10月22日,Anbio Biotechnology(NNNN)收跌0.27%,报3.72美元,成交额42.28万美元,市值5.35亿美元。 该公司致力于医疗技术开发和体外诊断(IVD)产品供应。其产品为非处方药(OTC)、即时诊断(POCT)和实验室应用提供解决方案,确保医疗保健提供者和患者在任何环境下都能获得可靠高效的诊断工具。其IVD产品可检测关键医疗领域的各种生物标志物,包括传染病、癌症、 ...
The Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) has published the Recruitment 2026 notification for the post of ...
Boost ROI through supply chain diversification, pricing optimization, strategic partnerships, and investment in AI-driven PCR and Next-Generation Sequencing solutions.Dublin, Oct. 21, 2026 (GLOBE ...
Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Mexico Genomics Market Size, Share, Trends and Forecast by Component, Application, Technology, End-User, and Region, 2026-2034" has been added to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results